Technical Articles
Solid tumor
Advances in Novel TCR Therapies Targeting KRAS G12V Mutation and Prospects for Protein Degradation Strategies
The KRAS gene is one of the most commonly mutated driver genes in various solid tumors, with the G12V mutation being the second most frequent subtype at codon 12 after G12D, frequently occurring in malignancies such as pancreatic cancer and colorectal cancer.
View details
- Cancer
- KRAS[G12V]/CRBN PROTAC Kit
- Solid tumor
- Protein degradation
Research Progress on TCE and PROTAC Technologies Targeting KRAS[G12V]
KRAS[G12V], as one of the key mutation types at codon 12 of the KRAS gene, exhibits a significant distribution in various solid tumors.
View details
- Cancer
- KRAS[G12V]/CRBN PROTAC Kit
- Solid tumor
- T cell engager
- 1








![靶向KRAS[G12V]的TCE与PROTAC技术研究进展](https://univ-shop.oss-cn-shanghai.aliyuncs.com/pc/images/20260112/103b0dfb52d74b8b8c2e5eeeb4b51cbb.png)





